期刊文献+

继发性甲状旁腺功能亢进的发病机制和诊治 被引量:9

Pathogenesis and diagnosis of secondary hyperparathyroidism
在线阅读 下载PDF
导出
摘要 继发性甲状旁腺功能亢进(secondary hyperparathyroidism,SHPT)是慢性肾脏病(chronic kidney disease,CKD)常见的并发症,大大增加了患者的病死率。但其发病机制复杂,疾病的不同时期采用的治疗手段亦不相同。本文将结合以往研究,对CKD患者并发SHPT的发病机制及诊治进行综述,为临床工作提供参考。 As a common complication of chronic kidney disease(CKD),secondary hyperparathyroidism(SHPT)greatly increases the mortality of patients.However,its underlying pathogenesis is rather complex and its treatments vary during different stages of disease.In conjunctions with previous studies,the pathogenesis,diagnosis and treatment of SHPT in CKD patients were reviewed for providing references for clinical practices.
作者 张洪彬 赵寒辉 王素霞 柳刚 Zhang Hong-bin;Zhao Han-hui;Wang Su-xia;Liu Gang(Department of Nephrology,No.960 Hospital of PLA Joint Logistics Support Force,Jinan 250031,China;Department of Nephrology,Second Hospital,Cheeloo College of Medicine,Nephrology Research Institute,Shandong University,Jinan 250033,China)
出处 《临床肾脏病杂志》 2021年第11期950-956,共7页 Journal Of Clinical Nephrology
基金 山东省重点研发计划(2017GSF18113)。
关键词 继发性甲状旁腺功能亢进 慢性肾脏病 甲状旁腺激素 Emphysematous pyelonephritis Acute kidney injury Surgical intervention
  • 相关文献

参考文献9

二级参考文献54

  • 1胡建明,吴宏飞,王笑云,俞香宝,赵奕华,沈霞,刘佳,孙彬,邢昌赢,杨俊伟.肾性甲状旁腺功能亢进症甲状旁腺全切加前臂移植31例临床分析[J].中华内科杂志,2006,45(9):714-716. 被引量:28
  • 2G aasbeek A,Meinders E.Hypophosphatemia:An update on its etiology and treatment[J].Am J Med,2005,118:1094-1101.
  • 3Tentori F.Mineral and bone disorder and outcomes in hemodialysis patients:results from the DOPPS[J].Semin Dial,2010,23:10-14.
  • 4Kong X,Zhang L,Zhang L,et al.Mineral and bone disorder in Chinese dialysis patients:a multicenter study[J].BMC Nephrol,2012,21:116.
  • 5Palmer SC,Hayen A,Macaskill P,et al.Serum levels of phosphorus,parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis[J].JAMA,2011,305:1119-1127.
  • 6Floege J,Kim J,Ireland E,et al.Serum iPTH,calcium and phosphate,and the risk of mortality in a European haemodialysis population[J].Nephrol Dial Transplant,2011,26:1948-1955.
  • 7Slatopolsky E,Moe S.50 years of research and discovery in chronic kidney disease and mineral & bone disorder:the central role of phosphate[J].Kidney Int Suppl,2011,121:S1-S2.
  • 8Danese MD,Belozeroff V,Smirnakis K,et al.Consistent control of mineral and bone disorder in incident hemodialysis patients[J].Clin J Am Soc Nephrol,2008,3:1423-1429.
  • 9Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].Kidney International 2009,76 (Suppl 113):S1-S130.
  • 10Pierratos A.Nocturnal home haemodialysis:an update on a 5-year experience[J].Nephrol Dial Transplant,1999,14:2835-2840.

共引文献248

同被引文献100

引证文献9

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部